ARCHIVES

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 32 No. 29 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

NCI to Fund Research Collaboration At HMOs, Health Care Provider Networks

July 11, 1997

Cytopathologists, NCI Recommend New Method For Pap Smear Reports

August 25, 1989

Congress Okays NIH Reauthorization, Allows NCI $472 Mil. More

June 12, 1992

“Don’t Judge Me On a Snapshot In Time,” Broder Says In Responding To Criticisms By Cancer Centers

July 7, 1989

News Analysis: The Political Economy of Importation to Alleviate Cancer Drug Shortages

March 2, 2012